Measles Outbreak Leads to Dangerous Vitamin A Toxicity
Trump Administration to Cut 10,000 Health and Human Services Jobs
Open-Label Placebo Plus Treatment Rationale Effective for PMS
Mean symptom intensity, mean interference lower for OLP with treatment rationale versus treatment as usual
Adverse Outcomes Increased With Long-Term Inhaled Corticosteroids in COPD
Significantly greater composite adverse outcome rates seen for long- versus short-term inhaled corticosteroid use for prevalent, inception cohorts
Combination Lipid-Lowering Therapy Linked to Greater Drop in LDL-C
Greater reduction seen in LDL-C; reductions also seen in all-cause mortality, major adverse CV events, stroke incidence
Pelabresib Plus Ruxolitinib Improves Underlying Myelofibrosis
In a recent study, significantly more patients receiving the combination therapy met primary end point of reduction in spleen volume of ≥35 percent from baseline
Kansas and Ohio Report Surge in Measles Cases Amid Outbreaks
Even without these two expanding clusters, the total number of cases in the U.S. has exceeded the case count for the entire year of 2024
Heart Failure Patients With Ejection Fraction Improvement Rarely Withdrawn From Meds
Withdrawing renin-angiotensin inhibitors/angiotensin receptor-neprilysin inhibitors and mineralocorticoid receptor antagonists tied to higher one-year mortality, morbidity
Coverage for Routine Childhood Vaccines Remains Below Prepandemic Levels
Vaccine series completion for rotavirus, DTaP, PCV at 12 months was highest in January 2020 and remained lower in October 2023
